SMTL ID : 9ba9.1

O-GlcNAcase (OGA) inhibitor complex for the Treatment of Alzheimer's Disease

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

homo-dimer

Ligands

2 x 01: N-{5-[(piperidin-1-yl)methyl]-1,3-thiazol-2-yl}acetamide

01.1: 13 residues within 4Å: Chain A: G.15, Y.17, K.46, D.122, C.163, Y.167, T.198, V.202, W.226, N.228, D.233, Y.234, N.261 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:D.122, A:Y.167, A:W.226, A:Y.234 Hydrogen bonds: A:K.46, A:D.122, A:D.122, A:N.228 Salt bridges: A:D.233 01.2: 13 residues within 4Å: Chain B: G.15, Y.17, K.46, D.122, C.163, Y.167, T.198, V.202, W.226, N.228, D.233, Y.234, N.261 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:D.122, B:Y.167, B:W.226, B:Y.234 Hydrogen bonds: B:K.46, B:D.122, B:N.228 Salt bridges: B:D.233

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kielbasa, W. et al., Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease. Alzheimers Dement (N Y) (2024)

Release Date

2025-01-15

Peptides

Protein O-GlcNAcase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Protein O-GlcNAcase